Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Stress incontinence" patented technology

Stress incontinence occurs when your bladder leaks urine during physical activity or exertion. It may happen when you cough, lift something heavy, change positions, or exercise.

Therapeutic methods for treating tissue

ActiveUS12661259B2Therapeutic coolingTherapeutic heatingStress incontinenceNon invasive
A method for treating urinary stress incontinence. The method includes non-invasively cooling target tissue during a first cooling step, a non-cooling step, and non-invasively cooling the target tissue in a second cooling step. The first cooling step, the non-cooling step, and the second cooling step are performed at predetermined temperatures for a predetermined period of time.
Owner:INMODE LTD +1

Stress urinary incontinence treatment system and methods

PCT designated stageWO2026090329A1Organic active ingredientsSurgical needlesDisplay deviceStress incontinence
A system (100) for treating stress urinary incontinence in a patient includes a cystoscope (102) including a probe assembly (104) with a shaft (110) having a tip, an optical element (112) for capturing images, a display (118) or optical viewer for presenting the images; a rotatable sheath (400) with a shaft and at least one lumen configured to receive the cystoscope shaft, the sheath being rotatable about the cystoscope shaft: and a treatment needle (500) insertable through the sheath, the needle configured to inject a treatment agent into tissue, wherein the treatment agent comprises a non-animal stabilized hyaluronic acid.
Owner:TELEFLEX LIFE SCIENCES LLC

Traditional Chinese medicine preparation for treating stress urinary incontinence and preparation method thereof

The invention relates to a traditional Chinese medicine preparation for treating stress urinary incontinence, the traditional Chinese medicine preparation is prepared from rhizoma bletillae polysaccharide, asiaticoside, fructus cnidii essential oil, cinnamon essential oil and pharmaceutically acceptable auxiliary materials, and the pharmaceutically acceptable auxiliary materials comprise a gel matrix material, a humectant, a preservative, a pH regulator and a solvent. The rhizoma bletillae polysaccharide, the asiaticoside, the fructus cnidii essential oil and the cinnamon essential oil in the traditional Chinese medicine preparation are matched with one another, the excellent technical effect of synergistic interaction is achieved, the defect that the effect of treating stress urinary incontinence through a single active ingredient is limited is overcome, and the increasing treatment requirements of patients suffering from stress urinary incontinence can be met.
Owner:JIANGSU WEINA PHARM TECH CO LTD

Pelvic floor muscle exercising device for stress urinary incontinence

The utility model discloses a pelvic floor muscle exercising device for stress urinary incontinence, relates to the technical field of exercising equipment, and solves the problems that some existing pelvic floor muscle exercising auxiliary instruments in the market are limited in function, so that a user often needs to purchase various instruments, the cost is high, the occupied space is large, and the exercising complexity is increased. A pelvic floor muscle exercising device for stress urinary incontinence comprises a fixed seat; the fixing base is of a rectangular plate structure. A supporting rod is fixedly arranged at the top of the rear side of the fixed seat; the supporting rod is of a cylindrical structure. The two sides of the supporting rod are each fixedly provided with a set of fixing plates of a T-plate structure. Two second sliding rods of L-shaped rod structures are arranged in the circular through groove in the front side of the fixing plate in a sliding mode. Connecting plates of arc-shaped plate structures are fixedly arranged at the inner side ends of the two second sliding rods. The sitting posture exercise mode and the standing posture exercise mode are integrated, a user does not need to purchase instruments with different functions, and cost and space are greatly saved.
Owner:SHANXI CANCER HOSPITAL

Postpartum female stress urinary incontinence risk assessment method based on pelvic floor ultrasonic imaging technology

The invention belongs to the technical field of medical treatment. The invention discloses a postpartum female stress urinary incontinence risk assessment method based on a pelvic floor ultrasonic imaging technology. The method comprises the following steps that S1, data are acquired and processed to form a tested object cluster; s2, performing SUI follow-up assessment on the tested object cluster; s3, dividing a data set of the tested object cluster; s4, constructing a risk assessment prediction model based on scoring; s5, constructing and visualizing a basic clinical model and a clinical-ultrasound joint model based on risk scores; and S6, performing postpartum SUI risk assessment. The system and the method have the advantages that the SII risk level can be quantitatively evaluated to formulate an individual follow-up visit scheme for implementing hierarchical dynamic management on high-risk groups to form a doctor-patient collaborative dynamic management mode, and the postpartum middle and long-term SII morbidity rate is effectively reduced.
Owner:THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV

Acellular matrix for treating stress urinary incontinence as well as preparation method and application of acellular matrix

PendingCN121846376APharmaceutical delivery mechanismTissue regenerationAcellular matrixSphincter
The invention provides an acellular matrix for treating stress urinary incontinence as well as a preparation method and application of the acellular matrix. Splitting the soft tissue by using a cell lysis solution to remove cell debris; removing nucleic acid, degreasing and then micronizing; and adding the soft tissue particles and the soft tissue cross-linked particles into a phosphate buffer solution according to a ratio, mixing and emulsifying to obtain the acellular matrix for injection for treating stress urinary incontinence. The cell removal rate reaches 99%, the fat residue is less than 0.3%, and the injection is injected around the sphincter of the urethra (middle section or bladder neck) and / or in the urethra according to 0.5 ml / point and 3-4 points during clinical application to play roles in filling, connecting and repairing tissues, so that the damaged urethra supporting structure is repaired, the structural integrity and strength of connective tissues and the sphincter around the urethra are maintained, and the application prospect is wide. Therefore, the symptom of stress urinary incontinence is improved.
Owner:广州友瀚生物科技有限公司

Use of Guiling tablet in the preparation of a drug for treating stress urinary incontinence or bladder cough

PendingCN122140862APill deliveryUrinary disorderChronic coughEfficacy
The application belongs to the technical field of Chinese patent medicines, and provides a use of Guiling tablets in the preparation of a medicine for treating stress urinary incontinence or bladder cough. On the basis of the known efficacy of Guiling tablets, a commercially available Chinese patent medicine, for treating kidney deficiency causing asthma and lung deficiency causing chronic cough, the application uses the kidney tonifying and qi consolidating effect of Guiling tablets to treat stress urinary incontinence or bladder cough, and very significant effects are observed on the incontinence of urine caused by excessive cough and asthma due to kidney deficiency in the middle-aged and the elderly, especially in middle-aged and elderly women.
Owner:JILIN LIHUA DRUG